MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Globus Medical Market Cap 2011-2026 | GMED
As of April 13, 2026 Globus Medical has a market cap of $ 12.2 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Globus Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 B | 11.4 B | 9.53 B | 5.94 B | 6.72 B | 6.08 B | 5.28 B | 4.35 B | 4.48 B | 2.51 B | 2.37 B | 2.22 B | 2.14 B | 1.13 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.5 B | 1.13 B | 5.48 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 173.14 | -0.8 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
175 M | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.89 | - | $ 1.15 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
LENSAR
LNSR
|
71.3 M | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |